A tailored, app-based cognitive bias modification intervention designed to reduce anxiety in people living with Huntington's and Parkinson's disease. Digital Trails is developing the app and supporting its rollout into a clinical trial.
Anxiety is common and burdensome for people with Huntington's disease (HD) and Parkinson's disease (PD). Cognitive bias modification for interpretation bias (CBM-I) — a technique that helps people reinterpret ambiguous situations in less threatening ways — may help, but it has not previously been tested in these populations. The team trialed a web version of their CBM-I intervention (MindTrails) and found that a tailored, movement-disorders-specific version is needed.
MindTrails-Movement adapts the intervention for HD and PD using a human-centered design (HCD) process, then tests it in a pilot randomized controlled trial.
The pilot RCT collects data every two weeks across the six-week intervention, plus a four-week follow-up, to assess both short-term and sustained effects. Groups are stratified by diagnosis (HD vs PD), and analysis of these and other subgroup differences will inform a planned follow-up R01.
App development ran from October 2023 through August 2025, with RCT recruitment beginning August 2025 and data collection scheduled to complete in September 2026.
Browse the full list of active studies and tools the team is building.